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The axon initial segment (AIS) is the site of action potential initiation and serves as a cargo 
transport filter and diffusion barrier that help maint in neuronal polarity. The AIS actin 
cytoskeleton is comprised of actin patches and periodic sub-membranous actin rings. We 
demonstrate that tropomyosin isoform Tpm3.1 co-localizes with actin patches, and that the 
inhibition of Tpm3.1 led to a reduction in the density of actin patches. Furthermore, Tpm3.1 
showed a periodic distribution similar to sub-membranous actin rings but Tpm3.1 was only 
partially congruent with sub-membranous actin rings. Nevertheless, the inhibition of Tpm3.1 
affected the uniformity of the periodicity of actin rings. Furthermore, Tpm3.1 inhibition led to 
reduced accumulation of AIS structural and functional proteins, disruption in sorting 
somatodendritic and axonal proteins, and a reduction in firing frequency. These results show that 








The proximal ends of axons in the vertebrate nervous system contain the axon initial segment 
(AIS). The AIS serves as the site of action potential initiation and plays a role in maintaining 
neuronal polarity. The clustering of sodium channels at the AIS facilitates spike generation (Kole 
et al., 2008), while its role in maintaining polarity s the result of a vesicle filter and diffusion 
barrier that restrict the entry of dendritic proteins and membrane lipids into the axon (Brachet et 
al., 2010; Nakada et al., 2003; Song et al., 2009; Sun et al., 2014; Winckler et al., 1999). The AIS 
is a remarkably stable structure comprising a specialized membrane and protein complex. 
Central to this complex is ankyrin G (Kordeli et al., 1995; Rasband, 2010), which acts as an 
adaptor that recruits other AIS proteins (Jenkins ad Bennett, 2001); ankyrin G recruits and 
binds to βIV-spectrin (Yang et al., 2007), neurofascin-186 (NF-186) (Ango et al., 2004), as well 
as sodium (Zhou et al., 1998) and KCNQ2/3 channels (Pan et al., 2006). The loss of ankyrin G 
leads to the loss of all other AIS components (Hedstrom et al., 2008; Jenkins and Bennett, 2001; 
Zhou et al., 1998). The interaction of ankyrin G with microtubules (Freal et al., 2016; Kuijpers et 
al., 2016; Leterrier et al., 2011) and the binding of βIV-spectrin to actin filaments (Jenkins and 
Bennett, 2001; Leterrier et al., 2015) link the AIS complex to the cytoskeleton. 
While recent studies have shed light on the role of microtubules in establishing and maintaining 
the AIS (Freal et al., 2016; Klinman et al., 2017; Kuijpers et al., 2016; van Beuningen et al., 
2015), the precise role of actin in the AIS remains u clear (Papandreou and Leterrier, 2018). 
Proper AIS development requires an intact actin cytoskeleton (Xu and Shrager, 2005), but the 
mature AIS is insensitive to actin-disrupting drugs (Abouelezz et al., 2019; Jones et al., 2014; 
Leterrier et al., 2015; Qu et al., 2017; Sanchez-Ponce et al., 2011; Song et al., 2009). This 
suggests that actin has no role in maintaining the structure of the AIS. Alternatively, actin 
filaments in the AIS may be resistant to the action of actin-disrupting drugs due to a low rate of 
turnover. Nonetheless, the integrity of the actin cytoskeleton is important for the AIS vesicle 
filter and diffusion barrier (Al-Bassam et al., 2012; Nakada et al., 2003; Song et al., 2009; 
Winckler et al., 1999). Platinum replica electron microscopy showed that the AIS contains both 
short, stable actin filaments, as well as longer, dynamic filaments (Jones et al., 2014). Actin-
based myosin motors play a role in the targeted delivery of somatodendritic and axonal vesicles 
(Janssen et al., 2017; Lewis et al., 2011; Lewis et al., 2009), and actin filaments form patches in 
the AIS (Balasanyan et al., 2017; Watanabe et al., 2012) that may serve as cargo transport filters 
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(Janssen et al., 2017; Leterrier and Dargent, 2014; Watanabe et al., 2012). While actin patches 
are not exclusive to the AIS, AIS actin patches are more stable than patches along the distal 
axon; the washing away of diffuse molecules by cellp rmeabilization led to the loss of actin 
patches in the distal axon, but not in the AIS (Watan be et al., 2012). In addition, recent work 
showed that the actin-based non-muscle myosin II isinvolved in AIS structure and plasticity 
(Berger et al., 2018; Evans et al., 2017) and associates with axonal F-actin (Wang et al., 2018; 
Wang et al., 2020). 
Super-resolution microscopy revealed the presence of p riodic, sub-membranous, actin rings in 
the axon, forming a lattice with spectrin and ankyrin (D'Este et al., 2015; Leite et al., 2016; Leite 
and Sousa, 2016; Leterrier et al., 2015; Xu et al., 2013; Zhong et al., 2014). It was thought that 
axonal actin rings have similar molecular architecture than the erythrocyte membrane skeleton 
(Bennett and Baines, 2001; Leite et al., 2016; Leite and Sousa, 2016; Xu et al., 2013), where 
short, stable, adducin-capped actin filaments also form a sub-membranous lattice with spectrin 
and ankyrin (Fowler, 2013). Actin filaments in the erythrocyte membrane skeleton are also partly 
stabilized by tropomyosins (Fowler and Bennett, 1984; Sung et al., 2000; Sung and Lin, 1994). A 
recent study combining the super-resolution with platinum-replica electron microscopy, using 
mechanical unroofing of cells, brought new information of neuronal sub-membranous actin rings 
showing that actin rings are made of two long, intertwined actin filaments (Vassilopoulos et al., 
2019). 
Taken together, it is now well appreciated that the AIS contains two types of actin structures - 
patches and sub-membranous actin rings. Actin filaments forming actin rings are resistant to F-
actin sequestering or severing drugs, suggesting they are stable (Abouelezz et al., 2019; 
Vassilopoulos et al., 2019). Currently, we lack information about the stability of F-actin in AIS 
actin patches. Furthermore, we know little about how the AIS actin cytoskeleton is regulated.  
In this study, we show that the actin filaments in patches have a relatively slow turnover rate. 
The slow turnover rate of AIS actin filaments encouraged us to examine the potential role of 
tropomyosins. Tropomyosins are actin-binding proteins that form coiled-coil dimers and play a 
role in the regulation of the actin cytoskeleton in a  isoform-specific manner (Gunning et al., 
2008). Based on preliminary testing of available tropomyosin constructs, we focused studies on 
tropomyosin 3.1 (Tpm3.1). Tpm3.1 localizes to the axons of developing neurons and was 
suggested to play a role in neuronal polarity (Hannan et al., 1995; Vindin and Gunning, 2013; 
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Weinberger et al., 1996). In addition, Tpm3.1 plays  role in regulating the filamentous actin 
pool in growth cones (Schevzov et al., 2008), growth cone motility (Fath et al., 2010), neurite 
branching (Schevzov et al., 2005a) and neurite extension (Stefen et al., 2018). Tpm3.1 binds F-
actin with high affinity (Gateva et al., 2017) and regulates the actions of key actin-binding 
proteins: (i) Tpm3.1 inhibits Arp2/3 complex-mediated polymerization (Kis-Bicskei et al., 2013), 
(ii) Tpm3.1 enhances the phosphorylation of actin-depolymerizing factor/cofilin (Bryce et al., 
2003) and inhibits the binding of cofilin to the pointed ends of actin filaments (Jansen and 
Goode, 2019), thus inhibiting filament severing as well as depolymerization at the pointed ends 
(Broschat, 1990; Jansen and Goode, 2019), (iii) Tpm3.1 recruits tropomodulin to the pointed 
ends (Sung and Lin, 1994), further lowering the rate of depolymerization (Weber et al., 1994; 
Yamashiro et al., 2014), and (iv) Tpm3.1 recruits and ctivates myosin II (Bryce et al., 2003; 
Gateva et al., 2017).  Here, we show that tropomyosin 3.1 (Tpm3.1) is part of the AIS actin 
cytoskeleton and is necessary for the maintenance of AIS structure and function. 
 
RESULTS 
The AIS contains patches of F-actin with a low rate of depolymerization 
Previous studies have revealed that actin forms patches in the AIS (Balasanyan et al., 2017; 
D'Este et al., 2015; Janssen et al., 2017; Jones et al., 2014; Leite et al., 2016; Leite and Sousa, 
2016; Leterrier et al., 2015; Watanabe et al., 2012; Xu et al., 2013; Zhong et al., 2014) that may 
play a role in the filtering of somatodendritic cargo (Balasanyan et al., 2017; Janssen et al., 2017; 
Watanabe et al., 2012). However, little is known about the dynamics and regulation of these 
actin patches. To investigate F-actin dynamics in the AIS, we expressed photoactivatable GFP-
tagged actin (PAGFP-actin) in cultured rat hippocamp l neurons (Koskinen and Hotulainen, 
2014; Patterson and Lippincott-Schwartz, 2002). We co-transfected neurons at 8-10 days in vitro 
(DIV) using mCherry and PAGFP-actin and imaged them 40-56 hours later. To label the AIS, 
we used an antibody against the extracellular domain of NF-186, 1-2 hours before imaging 
(Hedstrom et al., 2008). To visualize the distribution of F-actin in the AIS, we applied a brief 
405-nm laser pulse within a 30 µm-long region along the AIS (Fig. 1A). The fluorescence 
intensity within this region was monitored for 3 minutes by capturing a frame every 3 seconds. 
Due to the fast rate of diffusion of free actin monomers, the first frame taken after 
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photoactivation (0 s) enables the visualization of only those monomers that were immobilized by 
incorporation into an actin filament (Honkura et al., 2008). 
The distribution of F-actin in the AIS was uneven and a prominent patch under 1 µm in diameter 
showed a higher fluorescence intensity, corresponding to a higher concentration of F-actin (Fig. 
1B). Relative to the rest of the AIS, this actin patch was also the most long-lived (Fig. 1C). To 
measure the rate of depolymerization more accurately, we confined the photoactivation to a 
square area roughly 5 µm2 in size (Fig. 1D, red box). In addition to allowing for faster 
photoactivation, minimizing the area of photoactivation also minimizes the interference of 
photoactivated monomers that are incorporated into neighboring filaments after dissociation, 
leading to improved accuracy. Photoactivation was carried out within an AIS actin patch, in the 
AIS outside actin patches, and in a comparable dendritic segment that does not contain dendritic 
spines or branching points. An image was taken every 3 seconds and fluorescence intensity 
values were recorded. After subtracting the background fluorescence, we normalized the 
intensity values to the value at 0 s to obtain a normalized fluorescence decay curve. A double-
exponential decay function gave the best fit for the decay curves in all groups (Koskinen and 
Hotulainen, 2014), indicating the presence of two po ls of actin filaments with different rates of 
depolymerization. Accordingly, we fit the fluorescen  decay curves to a double-exponential 
decay function (Fig. 1E) and the fitting parameters were compared across groups. 
The average proportion of the stable fraction of actin filaments (Fig. 1F) was not significantly 
different between dendrites (21.1 ± 1.8%, mean ± SEM, n = 14, 4 independent experiments) and 
regions in the AIS outside the patches (23.0 ± 1.2%, mean ± SEM, n = 29, 6 independent 
experiments). Actin patches, however, had a higher proportion of stable filaments (34.4 ± 1.6%, 
mean ± SEM, n = 15, 7 independent experiments, p < 0.001, ANOVA, Tukey’s test). In contrast, 
using the same experimental setup we found the proporti n of stable actin filaments in dendritic 
spines to be 18% and 30% in cultured hippocampal neuro s at 14 and 21 DIV, respectively 
(Koskinen et al., 2014). Fig. 1G and h show the time constants for the dynamic and the stable 
pools of actin filaments, respectively. The average decay time constant of the dynamic pool was 
not significantly different between dendrites (12.76 ± 1.99 s, mean ± SEM, n = 14), regions in 
the AIS outside the patches (13.66 ± 1.16 s, mean ± SEM, n = 29), and actin patches (20.2 ± .74 
s, mean ± SEM, n = 15, Mann-Whitney U test, Bonferroni corrected). The average decay time 
constant for the stable pool was not significantly different between dendrites (318 ± 25 s, mean ± 
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SEM, n = 14) and regions in the AIS outside the patch (367 ± 25 s, mean ± SEM, n = 29). This 
value was higher in the actin patches (533 ± 50 s, mean ± SEM, n = 15, p < 0.01, Mann-Whitney 
U test, Bonferroni corrected) indicating that filaments in the AIS actin patches have a lower rate 
of depolymerization. It is likely that sub-membranous actin rings in the AIS had a minimal 
contribution to the readout in these experiments. This is partly due to the relatively low amount 
of F-actin in the sub-membranous lattice compared to in racellular F-actin within the area 
activated (10-fold less overall F-actin, Supplementary figure 1). In addition, actin filaments in 
the sub-membranous rings are relatively stable (Abouelezz et al., 2019; Vassilopoulos et al., 
2019), possibly leading to a low rate of incorporation of PAGFP-actin monomers available for 
photoactivation. These data indicate that the AIS contains patches of F-actin that have a high 
proportion of stable filaments with a low rate of depolymerization. 
 
Tropomyosin isoform Tpm3.1 co-localizes with actin patches with slow turnover rate  
The slow depolymerization rate suggests that AIS actin patches either contain relatively long 
actin filaments or are stabilized by actin-binding proteins. Tropomyosins are a family of actin-
binding proteins that align along actin filaments and affect their characteristics. In neurons, 
altogether 12 isoforms are expressed (Gray et al., 2017) from Tpm1, Tpm3 and Tpm4 genes. We 
examined the localization of available tropomyosin constructs and from tested constructs, only 
Tpm3.1 was present in the AIS. YFP-Tpm3.1 expression howed bright puncta in the AIS and 
the distal axon, and a diffuse distribution in the somatodendritic domain (Fig. 2A). In contrast, 
the expression of the closely related YFP-tagged tropomyosin isoform Tpm3.2 (sharing 7 of 8 
exons) showed a faint and diffuse distribution in the AIS and distal axon, and mild enrichment in 
dendritic spines (Supplementary figure 2A). Therefor , we focused our further experiments on 
Tpm3.1. 
 
We next wanted to test whether endogenous Tpm3.1 shows a similar staining pattern as YFP-
Tpm3.1 and whether Tpm3.1 patches co-localize with actin patches. Epifluorescence imaging of 
anti-Tpm3.1/2 antibody γ/9d-staining showed patchy labeling (Supplementary figure 2B). Super-
resolution structured illumination microscopy (SIM) imaging of phalloidin and γ/9d-antibody 
staining distribution revealed that patchy distribution of F-actin and Tpm3.1 co-localized (Fig. 
2B). γ/9d-antibody recognizes both Tpm3.1 and Tpm3.2, but as Tpm3.2 was absent from the 
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AIS, we assumed that the fluorescence intensity detect d using this antibody in the AIS 
originates from binding of Tpm3.1. Furthermore, we used PAGFP-actin to locate an actin patch 
with a low rate of depolymerization, then used anti-γ/9d to examine Tpm3.1 distribution. Tpm3.1 
immunofluorescence showed a high intensity at the actin patch with slow PAGFP-actin 
fluorescence decay (Fig. 2C, arrowheads), indicating that Tpm3.1 colocalizes with actin patches 
in the AIS (Fig. 2E). Conversely, Tpm3.1 patches were resistant to detergent extraction 
(Supplementary figure 2C), indicating cytoskeletal association. On average, the intensity of 
Tpm3.1 was 2.5 times higher in patches than in the AIS overall, including patches (mean ± SEM: 
2.52 ± 0.18, n = 25, 5 independent experiments).   
Based on these data, we conclude that Tpm3.1 is present in the AIS and co-localizes with actin 
patches.  
 
Tropomyosin isoform Tpm3.1/2 is part of the periodic AIS actin cytoskeleton 
In addition to patches, actin filaments in the AIS organize into periodic, sub-membranous rings, 
forming a lattice with spectrin and ankyrin (D'Este et al., 2015; Leite et al., 2016; Leite and 
Sousa, 2016; Leterrier et al., 2015; Xu et al., 2013; Zhong et al., 2014). We used SIM to test if 
Tpm3.1 also decorated actin filaments in these sub-membranous rings in cultured rat 
hippocampal neurons at 14 days-in-vitro (DIV). We used anti-γ/9d and Alexa 488-tagged 
phalloidin to visualize Tpm3.1 and F-actin, respectively. Anti-ankyrin G served to label the AIS. 
We optimized imaging parameters to visualize anti-γ/9d, tagged using Alexa-647. Similar to sub-
membranous F-actin, Tpm3.1 showed a periodic distribution in the AIS (Fig. 3A). To quantify 
the periodicity of Tpm3.1, we plotted fluorescence intensity profiles along regions in the AIS 
with visible periodicity and calculated the autocorrelation function for each profile. The average 
autocorrelation for the profiles measured showed an autocorrelation peak at a lag of 200 nm for 
both F-actin and Tpm3.1 (Fig. 3B and C, left panels). Owing to the pixel size of the camera used 
(40 nm), the distances recorded are multiples of 40. Accordingly, a lag of 200 nm corresponds to 
the ∼190 nm reported earlier for actin rings and other components of the AIS sub-membranous 
lattice (D'Este et al., 2015; Leite et al., 2016; Leterrier et al., 2015; Xu et al., 2013; Zhong et al., 
2014). For both F-actin and Tpm3.1, we measured the distance between individual neighboring 
fluorescence intensity peaks in each profile (Fig. 3B and C, right panels). The mean inter-peak 
distance for F-actin was 190.36 ± 1.7 nm (mean ± SEM), with 37.7% of the profiles 200 nm 
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apart. The mean inter-peak distance for Tpm3.1 was 200.98 ± 1.5 nm (mean ± SEM), with 
47.1% of the distances measuring 200 nm. In distal axons and dendrites, Tpm3.1 showed less 
uniform periodicity compared to the AIS (Supplementary figure 3). Despite the similar inter-
peak distance between F-actin and Tpm3.1 in the AIS, their distribution was only partially 
overlapping (Supplementary figure 4). Taken together, Tpm3.1 shows similar periodicity with 
sub-membranous F-actin rings. Tpm3.1 periodicity is most uniform in the AIS, while dendrites 
and distal regions of axons show less strict periodic ty. The partial overlap of actin and Tpm3.1 
suggests that Tpm3.1 is linked to sub-membranous actin rings but actin ring filaments are not 
necessarily aligned with Tpm3.1. 
 
Tpm3.1 is required for maintaining the structure of the AIS 
We next examined the consequences of the perturbation of Tpm3.1 function for AIS structure. 
We used two distinct, well-characterized, small-molecu e Tpm3.1 inhibitors, namely TR100 
(Bonello et al., 2016; Kee et al., 2018; Kee et al., 2015; Stehn et al., 2013) and Anisina 
(ATM3507) (Currier et al., 2017; Janco et al., 2019; Stehn et al., 2016) to inhibit Tpm3.1 and 
examined the accumulation of ankyrin G and other AIS markers at the AIS in mature cultured rat 
hippocampal neurons. TR100-mediated inhibition of Tpm3.1 does not inhibit the binding of 
Tpm3.1 to actin filaments, but negates its effect on the rate of depolymerization (Bonello et al., 
2016). The effects of TR100 on glucose-stimulated insulin secretion from the pancreatic islets 
were not seen in Tpm3.1 knockout mice, indicating that the impact of TR100 on glucose-
stimulated insulin secretion was on-target  (Kee et al., 2018). Similarly, Anisina (ATM3507) 
incorporates into the 4-helix coiled coil overlap junction of the Tpm3.1 dimer as it binds to actin 
filaments, changing its lateral movement along the actin filament and altering the interactions of 
the actin filament with actin binding proteins and myosin motors (Janco et al., 2019). 
We incubated sparse cultures of rat hippocampal neuro s at 10 DIV using DMSO (0.2%), TR100 
(10 or 15 µM), or Anisina (5 or 7.5 µM) for 2, 3, or 6 hours and then used anti-ankyrin G to 
visualize the distribution of ankyrin G. Anti-MAP2 served to label the somatodendritic domain. 
Both TR100- and Anisina-mediated Tpm3.1 inhibition led to a notable reduction in the 
accumulation of ankyrin G at the AIS (Fig. 4A). To quantify the reduction in ankyrin G 
accumulation, we blindly traced the fluorescence int nsity profile of ankyrin G along the initial 
30 µm of every neurite to calculate an AIS localization index (ALI, see Transparent Methods) 
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(Fig. 4B). For all treatment conditions, the ALI was lower than the corresponding DMSO 
controls (Fig. 4C). The mean ALI was negatively correlated with the concentration of both 
TR100 (Pearson’s coefficient; 2 hours: -1.0; 3 hours: -0.98; 6 hours: -0.97) and Anisina 
(Pearson’s coefficient; 2 hours: -0.99; 3 hours: -0.98; 6 hours: -0.98), as well as with the duration 
of the treatment (Pearson’s coefficient; TR100 10 µM: -0.94; TR100 15 µM: -1.0; Anisina 5 µM: 
-0.90; Anisina 7.5 µM: -0.90), suggesting dose- andtime-dependence. We similarly observed a 
reduction in the mean ALI of ankyrin G after overnight inhibition of Tpm3.1 (Supplementary 
figure 5A and B). Tpm3.1 inhibition also abolished the accumulation at the AIS of all other AIS 
markers tested, namely TRIM46, EB1, and neurofascin-186 (Supplementary figure 5C-F). 
While the loss of AIS structure upon Tpm3.1 inhibition using either TR100 or Anisina was clear, 
it is possible that this was a secondary effect rising from a general decay in neuronal health 
rather than a direct effect of the perturbation of Tpm3.1 function. In fact, oxidative stress (Clark 
et al., 2017) and neuronal injury (Schafer et al., 2009) resulted in the disruption of the AIS in a 
calpain-mediated manner. Schafer et al. (2009) showed that neuronal injury induced irreversible 
AIS disassembly through calpain-mediated proteolysis of ankyrin G and βIV-spectrin. However, 
this process was blocked by using the calpain inhibtor MDL28170. Thus, to test whether a 
similar calpain-dependent mechanism contributes to the loss of the AIS upon Tpm3.1 inhibition, 
we added calpain inhibitors to TR100 or Anisina trea ments and measured the ALI of ankyrin G. 
Indeed, the loss of AIS structure upon Tpm3.1 inhibition was calpain-independent; the mean ALI 
for all treatment conditions did not significantly change in the presence of 100 µM of the calpain 
inhibitor MDL28170 for the entire duration of the tr atment (Supplementary figure 5G). 
To verify that the loss of ankyrin G accumulation at the AIS is a result of the loss of Tpm3.1 
function, we generated a conditional knockout mouse model (Tp9 line, Supplementary figure 6, 
See Transparent Methods) for all Tpm3 isoforms containing exon 1b (namely Tpm3.1, Tpm3.2, 
Tpm3.3, Tpm3.4, Tpm3.5, Tpm3.7, Tpm3.8, Tpm3.9, Tpm3.12, and Tpm3.13). We plated 
dissociated hippocampal neurons from these mice onto PDL-coated coverslips. To induce protein 
depletion, we transduced cultures using CMV-EGFP-Cre adeno-associated viruses (UNC Vector 
Core Facility). This resulted in a 10% transduction efficiency leading to a mixture of wild-type 
neurons and neurons with reduced Tpm3 level. Alternatively, we used CMV-EGFP adeno-
associated viruses to transduce GFP—but not Cre—expression in sister cultures as controls. We 
confirmed the reduction of Tpm3 isoforms through immunostaining using an anti-Tpm3 
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antibody 2G10.2 (Supplementary figure 7). We then used anti-ankyrin G to visualize the 
accumulation of ankyrin G at the AIS. We first analyzed the intensity of ankyrin-G staining in 
GFP or Cre-GFP transfected cells (Fig. 5B) and additionally, we analyzed the ALI as we did for 
TR100 and Anisina –treated cells (Fig. 5C). The effect in cells from the conditional Tpm3 KO 
line with Cre expression was milder than that observed with the acute small-molecule inhibition. 
This milder effect is likely the result of residual Tpm3.1/2 present at the time of analysis.  
As tropomyosins are a large family containing numerous isoforms obtained by alternative 
splicing from four different genes, we wanted to test whether the effect on ankyrin G 
accumulation at the AIS was tropomyosin gene specific or if knocking out any Tpm gene will 
lead to the same effect. Therefore, we repeated the exp riment with conventional Tpm4 knockout 
mice (Tp16 line) (Pleines et al., 2017). Neurons dissociated from this mouse line did not show 
any detectable difference in the accumulation of ankyri  G at the AIS (Supplementary figure 8). 
These data indicate that tropomyosin-dependent accumulation of ankyrin G at the AIS is Tpm3 
gene-specific. 
Furthermore, we obtained similar results by expressing hRNA specific to exon 9d for 4 days, 
which only depletes Tpm3 isoforms Tpm3.1 and Tpm3.2 (Supplementary figure 9A-C). 
Similarly to experiments carried out with conditional Tpm3 knockout cells, Tpm3.1/2 protein 
level was only partially reduced, similarly leading to an effect, milder than that seen with acute 
inhibition of Tpm3.1. However, this effect was rescued by over-expressing YFP-tagged human 
Tpm3.1, which differs in sequence within the shRNA-targeting region, implicating that the 
shRNA-induced effect was indeed dependent on Tpm3.1 expression level (Supplementary figure 
9D and E). Thus, we conclude that both pharmacological inhibition and genetic depletion of 
Tpm3.1 cause a notable defect in AIS structure. Together, these data suggest that the reduced 
accumulation of ankyrin G at the AIS is the result of he loss of Tpm3.1 function, indicating that 
Tpm3.1 is necessary for maintaining the structure of the AIS. 
 
Tpm3.1 is necessary for maintaining the selectivity of axonal transport and sodium channel 
clustering at the AIS 
Cargo transport filtering and the diffusion barrier at the AIS require an intact actin cytoskeleton 
(Song et al., 2009; Winckler et al., 1999). Somatodendritic cargo entering the AIS halt at regions 
of high F-actin concentration, in a process that is dependent on myosin motors (Balasanyan et al., 
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2017; Janssen et al., 2017; Watanabe et al., 2012). To test if Tpm3.1 is required for maintaining 
the AIS cargo transport filter, we fixed sparse cultures of rat hippocampal neurons at 10 DIV 
after an overnight treatment using DMSO (0.2%), LatB (5 µM), or TR100 (5 µM) and used 
antibodies against the somatodendritic glutamate receptor subunit GluA1 to visualize its 
distribution. Anti-MAP2 served to label the somatoden ritic domain. Contrary to the 
somatodendritic localization of GluA1 observed in DMSO-treated neurons, we detected GluA1 
immunofluorescence in both the dendrites and axons of treated neurons (Fig. 6A). We used 
maximum intensity projection images from confocal stacks to blindly measure the mean 
fluorescence intensity along the axon and dendrites to calculate the axon-to-dendrite ratio for 
each group (Lewis et al., 2009). LatB-treated neurons showed a higher axon-to-dendrite ratio 
(0.38 ± 0.02, mean ± SEM, n = 15 neurons, 2 independent experiments, p < 0.01, Mann-Whitney 
U test) than DMSO-treated neurons (0.25 ± 0.03, mean ± SEM, n = 14 neurons, 2 independent 
experiments). TR100-treated neurons also showed a higher axon-to-dendrite ratio (0.49 ± 0.05, 
mean ± SEM, n = 18 neurons, 2 independent experiments, p < 0.001, Mann-Whitney U test) 
(Fig. 6b). This suggests that Tpm3.1 function is necessary for maintaining the selectivity of 
axonal transport at the AIS. 
In addition, we wanted to examine the effect of Tpm3.1 inhibition on the clustering of sodium 
channels, which is essential for spike generation at the AIS (Kole et al., 2008). This 
accumulation of channels is achieved through interac ions with ankyrin G (Jenkins and Bennett, 
2001; Zhou et al., 1998). We used antibodies against voltage-gated sodium channels (panNav) 
and the somatodendritic marker MAP2 to visualize sodium channel clustering at the AIS in 
sparse cultures of rat hippocampal neurons at 10 DIV after an overnight treatment using DMSO 
(0.2%), LatB (5 µM), or TR100 (5 µM). DMSO- and LatB-treated neurons showed clear 
detectable clustering of panNav immunofluorescence in the AIS, while TR100-treated neurons 
displayed a relatively homogenous distribution in all neurites (Fig. 7A). To quantitatively 
examine this effect, we used maximum intensity projections of confocal stacks to blindly record 
panNav immunofluorescence along the initial 30 µm of each neurite to calculate the ALI (Fig. 
7B). There was no difference in the mean ALI between DMSO-treated neurons (0.76 ± 0.02, 
mean ± SEM, n = 17 neurons, 3 independent experiments) and LatB-treated neurons (0.75 ± 
0.03, mean ± SEM, n = 17 neurons, 3 independent experiments). In contrast, TR100-treated 
neurons showed a lower ALI (0.37 ± 0.04, mean ± SEM, n = 17 neurons, 3 independent 
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experiments, p < 0.001, Mann-Whitney U Test), indicating a more homogenous distribution 
across neurites (Fig. 7C). These data suggest that Tpm3.1 is required for the clustering of sodium 
channels at the AIS. 
 
Tpm3.1 inhibition leads to a reduction in firing frequency and changes in action potential 
properties  
The initiation of action potentials is facilitated at the AIS by the clustering of ion channels (Kole 
et al., 2008), and is dependent on an intact AIS structure (Leterrier et al., 2017). To examine the 
effect of Tpm3.1 inhibition on spike generation, we r corded the activity of cultured rat 
hippocampal neurons at 16-18 DIV in current-clamp ex eriments in the presence of either 
DMSO (0.2%) or Anisina (2.5 µM). We introduced depolarizing steps of 100-200 pA at 10 s 
intervals and monitored the firing frequency 2 and 15 minutes after the introduction of DMSO or 
Anisina (Fig. 8A). The mean firing frequency of DMSO-treated neurons remained unchanged 15 
minutes after the introduction of DMSO (at 2 minutes: 18.3 Hz ± 2.9, mean ± SEM; at 15 
minutes: 20.9 Hz ± 4.2, mean ± SEM, n = 7 neurons, 5 independent experiments, paired-sample 
t-test). Conversely, Anisina-treated neurons showed a significant attenuation of firing frequency 
after 15 minutes (at 2 minutes: 21.7 Hz ± 4.2, mean ± SEM; at 15 minutes: 16.7 Hz ± 2.6, mean 
± SEM, n = 7 neurons, 5 independent experiments, p < 0.05, paired-sample t-test). The change in 
mean firing frequency 15 minutes after introducing DMSO (9.5% ± 7.0, mean ± SEM) was 
significantly different from that of neurons treated using Anisina (-20.9% ± 3.4, mean ± SEM, p 
< 0.01, two-sample t-test, Fig. 8B).  
To study the effects of Tpm3.1 inhibition by Anisina on action potential properties, we 
constructed phase plane plots using Clampex software (Fig. 8D, E). Tpm3.1 inhibition resulted 
in a shallower phase plot slope 104.50 ± 9.66 dV/dt compared to control neurons 160.15 ± 10.60, 
p < 0.05, n = 5 (Fig. 8F). The action potential threshold was slightly but not significantly lower 
in Anisina-treated neurons (-44.19 ± 2.256 mV and -39.93 ± 0.77 for control and Anisina-treated 
neurons, respectively, p = 0.065, n = 5) (Fig. 8G). These data indicate that Tpm3.1 is required for 
maintaining AIS function in the initiation of action potentials, consistent with the loss of sodium 
channel clustering at the AIS. 
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Tpm3.1 inhibition leads to the gradual reduction in the number of actin patches and 
uniformity of periodicity of the sub-membranous actin rings 
Our results show that Tpm3.1 is important for the accumulation of ankyrin G at the AIS, but it is 
not clear how Tpm3.1 inhibition leads to the loss of ankyrin G accumulation. We are not aware 
of any reports suggesting direct interaction between Tpm3.1 and ankyrin G. Thus, we 
hypothesized that the loss of Tpm3.1 function adversely affects the overall structure and 
organization of the actin cytoskeleton in the AIS. This disorganization would then ultimately 
lead to the loss of accumulation of ankyrin G and other structural AIS proteins (Hedstrom et al., 
2008; Jenkins and Bennett, 2001; Zhou et al., 1998). 
First, we tested the effect of Tpm3.1 inhibition on actin patches in the AIS. Tpm3.1 inhibition led 
to a reduction in the frequency of actin patches in the AIS compared to DMSO-treated neurons 
(DMSO: 0.58 ± 0.06 patches/µm, mean ± SEM, n = 13 neurons, 3 independent experiments; 
LatB: 0.71 ± 0.04 patches/µm, mean ± SEM, n = 13 neurons, 3 independent experiments, p = 
0.19; TR100: 0.42 ± 0.02 patches/µm, mean ± SEM, n = 13 neurons, 3 independent experiments, 
p < 0.05; Anisina: 0.3 ± 0.05 patches/µm, mean ± SEM, n = 12 neurons, 3 independent 
experiments, p < 0.001, ANOVA, Tukey’s test). 
Next, we tested whether Tpm3.1 inhibition affects actin rings. We employed super-resolution 
microscopy techniques to examine the periodicity of F-actin in the AIS. We treated sparse 
cultures of rat hippocampal neurons at 14 DIV using DMSO (0.2%), TR100 (10 µM), or Anisina 
(5 µM) for 6 hours. In addition, we treated cultures at DIV 13 using LatB (5 µM) overnight, 
similar to Winckler et al. (1999). Consistent with our earlier report (Abouelezz et al., 2019), 
LatB-treated neurons showed an overall lower phalloidin fluorescence intensity, reflecting a 
decrease in overall F-actin. Periodic actin rings were visible for all groups, indicating the 
persistence of the sub-membranous lattice, even in the absence of ankyrin G (Fig. 9A). We 
blindly plotted fluorescence intensity profiles in regions within the AIS where periodicity was 
visible and calculated the autocorrelation function. All groups showed autocorrelation at a lag of 
200 nm (Fig. 9B). Owing to the pixel size of the camera used (40 nm), the distances recorded are 
multiples of 40. Accordingly, a lag of 200 nm corresponds to the ∼190 nm reported earlier for 
actin rings and other components of the AIS sub-membranous lattice (D'Este et al., 2015; Leite et 
al., 2016; Leterrier et al., 2015; Xu et al., 2013; Zhong et al., 2014). In addition, we blindly 
measured the distance between individual peaks in each fluorescence intensity profile and 
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compared the distribution of the inter-peak distances across groups (Fig. 9C). 54% of the inter-
peak distances in DMSO-treated neurons were 200 nm, while the mean inter-peak distance was 
192.49 ± 1.37 nm, mean ± SEM. The distribution of the inter-peak distances in LatB-treated 
neurons was not significantly different from DMSO controls, with 51.2% of the inter-peak 
distances at 200 nm, and a mean inter-peak distance of 188.7 ± 1.38 nm, mean ± SEM (p = 0.47, 
Kolmogorov Smirnov test). In contrast, TR100-treated neurons showed a less uniform 
distribution with only 41.7% of the inter-peak distance at 200 nm, and a mean inter-peak 
distance of 182.7 ± 1.74 nm, mean ± SEM (p < 0.01, Kolmogorov Smirnov test). Similarly, only 
39.8% of the distances measured in Anisina-treated neurons were 200 nm, with a mean inter-
peak distance of 189.0 ± 1.94 nm, mean ± SEM, a distribution significantly different from 
DMSO controls (p < 0.01, Kolmogorov Smirnov test). We also obtained similar results using 
stochastic optical reconstruction microscopy (STORM) (Supplementary figure 10). When 
calculated on a cell-by-cell basis, the mean inter-peak distance in each group was not 
significantly different (Kruskal-Wallis ANOVA, p = 0.05). The mean coefficient of variation 
was also not significantly different among groups (Kruskal-Wallis ANOVA, p = 0.09). 
These results show that Tpm3.1 inhibition affects both AIS actin patches and actin rings. Tpm3.1 
inhibition reduced the number of actin patches in the AIS whereas LatB treatment increased their 
number. As shown before (Abouelezz et al., 2019), we found that the periodicity of sub-
membranous actin rings in the AIS was resistant to La B. As LatB disrupts the actin cytoskeleton 
through sequestering free actin monomers (thus inhibiting actin polymerization), stable actin 
filaments with a low rate of depolymerization may be less susceptible to LatB. In contrast, the 
inhibition of Tpm3.1 for the duration of the experiments (6 hours) disrupted—but did not 
entirely abolish—the periodicity of sub-membranous actin rings. In addition to changing the 
uniformity of the periodicity, visual inspection revealed that actin rings were often tilted after 
Tpm3.1 inhibition, losing their nature of parallel transverse stripes (Fig. 9A).  
 
Tpm3.1 depletion reduces myosin IIB expression   
The earlier experiments have mainly followed the ida that Tpm3.1 affects actin filament 
stability. However, in addition to playing a role in F-actin turnover, Tpm3.1 recruits and 
activates myosin IIB (Bryce et al., 2003; Gateva et al., 2017), and recent work has revealed an 
important role for myosin II in AIS structure (Bergr et al., 2018; Evans et al., 2017; Wang et al., 
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2018). In U2 Osteosarcoma cells, Tpm3.1/3.2 overlaps with non-muscle myosin II heads but not 
with non-muscle myosin II tails or α-actinin in stress fibres (Meiring et al., 2019). Thus, we 
examined the effect of perturbing Tpm3.1 in cultured n urons on myosin IIB. We expressed Cre-
GFP in cultured hippocampal neurons of Tpm3 conditional knockout mice (Tp9 line) using either 
viral transduction or lipofection and used anti-myosin IIB to examine myosin IIB distribution 
(Fig. 10). Neurons expressing Cre-GFP after viral tnsduction showed a lower intensity of 
myosin IIB immunofluorescence (0.72 ± 0.1, mean ± SEM, n = 12) relative to neighboring 
control neurons (1 ± 0.06, mean ± SEM, p < 0.05, two-sample t-test, n = 22, 3 independent 
experiments). Similarly, compared to neighboring contr l neurons (1 ± 0.05, mean ± SEM, n = 
31), neurons expressing Cre-GFP after lipofection showed a lower intensity of myosin IIB 
immunofluorescence (0.81 ± 0.06, mean ± SEM, p < 0.05, two-sample t-test, n = 12, 3 




Although an intact actin cytoskeleton is required for the formation of the AIS (Xu and Shrager, 
2005), the mature AIS is remarkably stable and insensitive to actin-disrupting drugs (Jones et al., 
2014; Leterrier et al., 2015; Sanchez-Ponce et al., 2011; Song et al., 2009). This may lead to the 
conclusion that the actin cytoskeleton has no significant role in the maintenance of AIS structure. 
The loss of accumulation of ankyrin G (Figs. 4, 5, S  and S9) and other AIS structural (Fig. S5) 
and functional proteins (Fig. 7), disruption in sorting somatodendritic and axonal proteins (Fig. 
6), and a reduction in firing frequency (Fig. 8) upon the perturbation of Tpm3.1 function, 
however, suggests otherwise.  
The AIS actin cytoskeleton comprises sub-membranous actin rings and actin-rich patches 
(Papandreou and Leterrier, 2018). While sub-membranous actin rings are not exclusive to the 
AIS (Bertling and Hotulainen, 2017; D'Este et al., 2015; Han et al., 2017; Leite et al., 2016; Leite 
and Sousa, 2016; Xu et al., 2013; Zhong et al., 2014), actin patches in the AIS are more 
numerous and resistant to extraction, compared to more distal axonal patches (Balasanyan et al., 
2017). Our data suggest that Tpm3.1 co-localizes with actin patches in the AIS (Figs. 2 and S2), 
and that the inhibition of Tpm3.1 led to a reduction in the number of AIS actin patches. In 
addition to patches, Tpm3.1 showed a periodic distribution similar to sub-membranous actin 
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rings but Tpm3.1 was only partially congruent with sub-membranous actin rings (Figs. 3 and 
S4). Nevertheless, the inhibition of Tpm3.1 affected the alignment of actin rings and the 
uniformity of their periodicity (Figs. 9 and S10). In addition to rings and patches, axons have 
other less characterized actin structures such as actin trails or hotspots (Ganguly et al., 2015). As 
the distribution of Tpm3.1 was not congruent with sub-membranous actin rings (Fig. S4), we 
propose that Tpm3.1 decorated actin filaments are ptially actin filaments of actin rings but 
partially actin filaments outside the rings. Currently it is unclear what exactly are the Tpm3.1 
decorated filaments outside the rings and patches. It is also possible that the inhibition of Tpm3.1 
affects the recruitment and accumulation of other actin-binding proteins that are important for 
maintaining actin rings or other actin structures in the AIS. Although the exact mechanism is still 
unclear, our data shows that Tpm3.1 provide support for the AIS structural complex.  
 
Tpm3.1 stabilizes actin filaments and recruits and activates myosin II 
Biochemically, Tpm3.1 was shown to have two main fuctions in actin filament regulation – it 
stabilizes actin filaments and regulates myosin IIB binding and contractility. Tpm3.1 enhances 
the phosphorylation (and inactivation) of actin-depolymerizing factor/cofilin (Bryce et al., 2003) 
and inhibits the binding of cofilin to the pointed nds of F-actin (Jansen and Goode, 2019), thus 
inhibiting filament severing as well as depolymerizat on at the pointed ends (Broschat, 1990). 
Furthermore, Tpm3.1 recruits tropomodulin to the pointed ends (Sung and Lin, 1994), further 
lowering the rate of depolymerization (Weber et al., 1994; Yamashiro et al., 2014). Thus, the 
inhibition of Tpm3.1 renders Tpm3.1-decorated actin filaments vulnerable to depolymerization 
(Bonello et al., 2016) and, therefore, it is plausible that the loss of AIS structure upon Tpm3.1 
inhibition is due to a reduction in the stability of actin filaments. Bach et al. (2009) showed that 
Tpm3.1 is required for stabilizing actin filaments in the formation and maturation of focal 
adhesions. Tpm3.1-decorated actin filaments are the least sensitive to latrunculin and 
Cytochalasin D (Creed et al., 2008; Percival et al., 2000). It is, therefore, expected that inhibiting 
Tpm3.1 function will have a substantial effect on actin filament dynamics in the AIS.  Altering 
the stability, length, or linearity of the actin filaments building the AIS may then lead to less 
organized structures (Tojkander et al., 2011). 
In addition to actin filament stabilization, Tpm3.1 recruits and activates myosin II (Bryce et al., 
2003; Gateva et al., 2017; Meijering et al., 2019), which has recently emerged as an important 
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regulator of AIS structure (Berger et al., 2018; Evans et al., 2017). Recent super-resolution and 
electron microscopy studies reported a subcellular ocalization of myosin IIB similar to what we 
detected for Tpm3.1 (Vassilopoulos et al., 2019; Wang et al., 2020). Myosin II also shows 
periodicity, but not as uniform as actin and it only partially overlaps with actin rings. 
Immunogold labeling for pMLC followed by PREM showed gold beads often appearing along 
filaments perpendicular to actin braids (Vassilopoulos et al., 2019). It is thus plausible that 
Tpm3.1 further contributes to the structure of the AIS by recruiting myosin II to the fibrillar coat, 
providing the lattice with contractile characteristic . This is supported by the relatively low 
myosin IIB immunofluorescence in Tpm3 KO neurons (Fig. 10). However, the reduced myosin 
IIB expression in Tpm3.1 KO cells is just the first indication of possible interaction of Tpm3.1 
and myosin IIB in neurons. Further experiments are required to clarify how Tpm3.1 affects 
myosin IIB in the AIS. One more alternative explanation for the loss of AIS structure upon 
Tpm3.1 inhibition could be that Tpm3.1 depletion or inhibition perturbs the specific interactions 
between Tpm3.1 and proteins contributing to the structure of the AIS; for example, by regulating 
the binding of βIV-spectrin to the sub-membranous actin rings. Again, further experiments are 
needed to elucidate which scenario is the correct one.
 
Tpm3.1 inhibitors and genetic manipulations affect actin filaments via different mechanisms  
We used here three techniques (small molecule inhibitors, conditional knockout and shRNA) to 
perturb Tpm3.1 function or expression. While the results all point in the same direction, Tpm3.1 
inhibitors resulted in a stronger decrease in ankyri  G intensity compared to genetic 
manipulation. However, there are good reasons for this difference. First, genetic manipulation 
(conditional knockout and shRNA) decreased Tpm3.1/2 levels, but with limited efficacy. This 
already gives an understandable explanation for the milder effects when protein levels are 
partially decreased versus an approach where protein function is totally blocked. Furthermore, 
genetic perturbation and drugs affect filaments differently. Genetic depletion leads to longer-
lasting protein level decrease and loss of a specific filament population can lead to compensating 
changes. In contrast, the anti-Tpm3.1 drugs do not prevent assembly of Tpm3.1-containing actin 
filaments (Bonello et al, 2016, Janco et al, 2019). Rather, the drugs incorporate into the 
Tpm3.1/actin filament and alter the function and stability of the filament (Bonello et al, 2016, 
Currier et al, 2017, Janco et al, 2019). In addition, their effects are quick, which avoids the 
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likelihood of compensatory changes in the cytoskeleton. Thus, even with 100% knockout 
efficiency, the drugs are expected to give more penetra t phenotypes than that observed with 
knock-out and shRNA strategies. It is also important o note that for the main result, we used two 
structurally distinct Tpm3.1 inhibitors, TR100 and Anisina, and hence, it is highly unlikely to 
have the same off-target impact.  
 
Tpm3.1 inhibition perturbs the functionality of the AIS 
It has been suggested that actin patches are important for cargo transport filtering (Janssen et al., 
2017; Leterrier and Dargent, 2014; Watanabe et al., 2012). Tpm3.1 inhibition indeed reduced the 
number of actin patches in AIS. In contrast, LatB trea ment did not decrease the number of 
patches in the AIS although it made the AIS leaky. It is possible, however, that LatB affected the 
turnover and functionality of the actin filaments in patches. Thus, the exact mechanism of how 
the actin cytoskeleton contributes to the regulation of cargo transport filtering is still unclear.  
 
The effect of Tpm3.1 inhibition by Anisina on firing frequency was relatively rapid (Fig. 8) 
suggesting that the high-order structure of the AIS, which is required for proper functionality of 
voltage-gated sodium channels is highly sensitive to Tpm3.1 inhibition. Phase-plane plots 
revealed shallower slopes of action potentials at +20 mV from threshold in Tpm3.1 blocked 
neurons, compared to control (Fig 8C-F), thus suggesting more proximal action potential 
initiation sites (Kress et al. 2007). The result is consistent with our immunofluorescence data 
showing redistribution and clustering of voltage-gated sodium channels to more somatic location 
in Tpm3.1 blocked neurons (Fig 7). The finding is al o in line with Kress et al. (2007) who 
showed that a shallower action potential slope is associated with more proximal voltage-gated 
sodium channel clustering in hippocampal granule cel fibers in comparison to CA3 pyramidal 
cells having a steeper action potential slope and more distal sodium channel clustering. However, 
since 15 min Anisina treatment may not have been sufficient to induce marked structural 
rearrangement of sodium channel localisation within t e axon, other mechanisms decreasing 
axonal voltage gated sodium channel function, such as disruption of sodium channels´ order or 
density at the AIS, may have come to play here. Taken together, Anisina treatment decreases 
excitability of neurons in a manner consistent with reduced functional sodium channel density at 
the AIS. Although the mechanistic details await furthe  study, the electrophysiological data give 
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strong functional support to our findings on the redistribution/functional change of sodium 
channels after Tpm3.1 inhibition.  
  
Taken together, we showed a novel characterization of Tpm3.1 as an AIS component and that its 
expression and functionality are required for the normal maintenance and functionality of AIS in 
primary hippocampal neurons.  
 
 
LIMITATIONS OF THE STUDY 
 
This study was limited to cultured primary hippocampal neurons. In the future, results need to be 
confirmed in in vivo models. It will be also interesting to see whether Tpm3.1 functionality is 
needed for other cell types. Based on our results, we expect that Tpm3.1-facilitated organization 
of the AIS is not needed in some neuron-types, suchas granule cells, where sodium channels are 
clustered at a different location. Furthermore, for example, Neurofascin depletion has been 
shown to have different influences in Purkinje cells versus hippocampal neurons (Zonta et al., 
2011; Leterrier et al., 2017). Currently, it is unclear whether different neuron types have different 
organizations and protein compositions in the AIS but this is a very interesting study question for 
the future. 
The Tpm3.1 isoform, as most tropomyosin isoforms, is nearly impossible to study without 
affecting or detecting other tropomyosin isoforms. In this study, conditional knockout was 
depleting all Tpm3 gene products and our shRNA was depleting Tpm3.1 and its close homologue 
Tpm3.2. Antibodies used against Tpm3.1 recognize both Tpm3.1 and Tpm3.2. Genetic depletion 
of Tpm3.1/2, both with conditional knockout cells (where depletion was induced with Cre 
infection) and shRNA-induced depletion, were limited. It may indicate that the degradation 
turnover of Tpm3.1/2 is relatively slow. 
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MAIN FIGURE TITLES AND LEGENDS 
 
Figure 1. F-actin patches in the AIS have a lower rate of depolymerization. 
(A) We performed photoactivation within the dashed-box representing the entire AIS in rat 
hippocampal neurons expressing mCherry and PAGFP-actin and monitored PAGFP fluorescence 
over time. PanNF186 served to label the AIS.  
(B) Higher magnification of the dashed-box in (A) showing PAGFP-actin fluorescence 3 seconds 
before, immediately after, and 60 seconds after photoactivation. Arrowhead indicates F-actin 
patch. 
(C) PAGFP-actin fluorescence intensity profile along the AIS over time. 
(D) We performed photoactivation in a dendrite, theAIS, or an F-actin patch in the AIS (‘AIS 
patch’). Photoactivation was limited to the small boxed region to enable a more accurate 
measurement of F-actin dynamics. Contour lines were constructed using mCherry fluorescence. 
(E) Average normalized fluorescence decay curve fits over time in dendrites, the AIS, and F-
actin patches in the AIS. We fit fluorescence decay urves to a double-exponential decay 
function and compared the fitting parameters across groups. 
(F) Percentage of the stable fraction in dendrites, he AIS, and AIS actin patches (ANOVA, 
Tukey’s test). 
(G) Time constants of the dynamic fractions (Mann-Whitney U test). 
(H) Time constants of the stable fractions (Mann-Whitney U test). 
Black circles represent mean value. Box borders represent the 25th and 75th percentiles, whiskers 
represent minimum and maximum values less than 1.5x the interquartile range lower or higher 
than the 25th or 75th percentiles, respectively (Tukey style). Dendrites: n = 14, 4 independent 
experiments; AIS: n = 29, 6 independent experiments; AIS patch: n = 15, 7 independent 
experiments. * denotes statistical significance. **: p < 0.01; ***: p < 0.001. Scale bar: 5 µm. See 




Figure 2. Tropomyosin Tpm3.1 decorates actin patches in the AIS. 
(A) Rat hippocampal neuron expressing YFP-Tpm3.1. Neurons were fixed 8 hours post-
transfection. Anti-ankyrin G served to label the AIS. Patches of YFP-Tpm3.1 can be seen in the 
AIS (white box) and distally in the axon (yellow box) while the somatodendritic domain (cyan 
box) shows a diffuse, less intense distribution. 
(B) Maximum intensity projection of 3D-SIM reconstructions for F-actin and Tpm3.1/2. 
Arrowheads indicate actin patch. Scale bar: 1 µm. 
(C) Actin patch visualized in live hippocampal neuron using PAGFP-actin before 
photoactivation (pre), immediately after activation (0 s) and the time-points indicated in seconds. 
Arrowheads indicate actin patch. 
(D) Fluorescence decay over time (gray diamonds) of the actin patch in (c) and a double-
exponential decay fit (solid black line). 
(E) Tpm3.1/2 distribution visualized using anti-γ/9d in the same area after fixation in 4% PFA. 
The intensity of Tpm3.1/2 immunofluorescence was higher in the region corresponding to the 
actin patch visualized in (C) (arrowhead). Scale bar: 5 µm. See also Figure S2. 
 
Figure 3. Tropomyosin isoform Tpm3.1 forms a periodic structure in the AIS. 
(A) SIM reconstruction of the AIS of a rat hippocampal neuron at 14 DIV labelled using anti-
γ/9d and Alexa-488 tagged phalloidin to visualize Tpm3.1 and F-actin, respectively. Anti-
Ankyrin G served to label the AIS. Tpm3.1/2 shows a periodic structure partially corresponding 
to actin rings in the AIS. Right: fluorescence intensity profile along the AIS. 
(B) Left: Average autocorrelation of normalized phalloidin fluorescence intensity profiles 
showing autocorrelation at 200 nm. Right: Distance between individual peaks in normalized 
phalloidin fluorescence intensity profiles. 37.7% of the peaks were separated by 200 nm. 
(C) Left: Average autocorrelation of normalized anti-γ/9d fluorescence intensity profiles 
showing autocorrelation at 200 nm. Right: Distance between individual peaks in normalized anti-
γ/9d fluorescence intensity profiles. 47.1% of the peaks were separated by 200 nm. n = 25 cells, 




Figure 4. Inhibition of Tpm3.1 reduces the accumulation of ankyrin G at the AIS. 
(A) Rat hippocampal neurons treated at 10 DIV using DMSO or the small-molecule Tpm3.1 
inhibitors TR100 or Anisina (ATM3507) for 2, 3, or 6 hours. Anti-MAP2 served to label the 
somatodendritic domain, anti-ankyrin G served to measure the accumulation of ankyrin G. 
Arrows point to axons. 
(B) Smoothed ankyrin G fluorescence intensity line profiles (gray lines) along each neurite of the 
corresponding cell in (A), normalized to the median peak value (black line). 
(C) AIS localization indices for neurons treated using DMSO, TR100 (10 or 15 µM), or Anisina 
(5 or 7.5 µM) for 2, 3, or 6 hours. All treatment groups were significantly different from DMSO 
controls (Mann-Whitney U test; DMSO 0.2%, 2 hours: 0.94 ±0.006, mean ± SEM; D SO 0.2%, 
3 hours: 0.93 ± 0.006; DMSO 0.2%, 6 hours: 0.96 ± 0.005; TR100 10 µM, 2 hours: 0.59 ± 0.050, 
p < 0.001; TR100 10 µM, 3 hours: 0.50 ± 0.051, p < 0.001; TR100 10 µM, 6 hours: 0.42 ± 
0.066, p < 0.001; TR100 15 µM, 2 hours: 0.45 ± 0.06, p < 0.001; TR100 15 µM, 3 hours: 0.42 
± 0.060, p < 0.001; TR100 15 µM, 6 hours: 0.35 ± 0.056, p < 0.001; Anisina 5 µM, 2 hours: 0.58 
± 0.055, p < 0.001; Anisina 5 µM, 3 hours: 0.49 ± 0.049, p < 0.001; Anisina 5 µM, 6 hours: 0.44 
± 0.039, p < 0.001; Anisina 7.5 µM, 2 hours: 0.51 ± 0.041, p < 0.001; Anisina 7.5 µM, 3 hours: 
0.41 ± 0.062, p < 0.001; Anisina 7.5 µM, 6 hours: 0.36 ± 0.075, p < 0.001; for each treatment, n 
= 12, 3 independent experiments). The mean ALI of the reatment groups was negatively 
correlated with treatment duration and concentration. Black circles represent mean values. Box 
borders represent the 25th and 75th percentiles, whiskers represent minimum and maximum 
values less than 1.5x the interquartile range lower or higher than the 25th or 75th percentiles, 
respectively (Tukey style). Dotted lines connect mean values. Scale bar: 5 µm. See also Figure 
S5.  
 
Figure 5 Tpm3 conditional knockout neurons show a reduced accumulation of ankyrin G at 
the AIS. 
(A) Ankyrin G immunofluorescence for GFP-(wild-type, WT) and Cre GFP-expressing (Tpm3 
KO) neurons. β3-Tubulin was used to label neurons. Arrowheads indicate transfected neurons, 
arrows indicate axons of transfected neuron. Scale bar: 5 µm. 
31 
 
(B) Average relative ankyrin G fluorescence intensity for each group (Mann-Whitney U test). 
Columns represent mean values. Error bars represent sta dard error of mean. GFP: n = 63, 3 
independent experiments; Cre-GFP: n = 61, 3 independent experiments. * denotes statistical 
significance. ***: p < 0.001. 
(C) AIS localization indices (ALI) for neurons infect d with GFP or Cre-GFP. The ALI of Cre-
GFP infected neurons (0.87 ± 0.02, mean ± SEM, n = 57, 3 independent experiments) was lower 
than GFP-infected controls (0.95 ± 0.002, mean ± SEM, n = 61, 3 independent experiment, p < 
0.001, Mann-Whitney U test). Black circles represent mean values. Box borders represent the 
25th and 75th percentiles, whiskers represent minimum and maximum values less than 1.5x the 
interquartile range lower or higher than the 25th or 75th percentiles, respectively (Tukey style). 
See also Figure S6-9. 
 
Figure 6. Tpm3.1 inhibition leads to the redistribution of the somatodendritic marker 
GluA1. 
(A) MAP2 and GluA1 immunofluorescence in rat hippocampal neurons incubated overnight at 
9-11 DIV in DMSO, LatB, or TR100. Dashed lines reprsent axons. 
(B) GluA1 axon-to-dendrite ratios were higher in LatB- and TR100-treated neurons (Mann-
Whitney U test). Black circles represent mean value. Box borders represent the 25th and 75th 
percentiles, whiskers represent minimum and maximum values less than 1.5x the interquartile 
range lower or higher than the 25th or 75th percentiles, respectively (Tukey style). DMSO 0.2%: n 
= 14, 2 independent experiments; LatB 5 µM: n = 14, 2 independent experiments; TR100 5 µM: 
n = 18, 2 independent experiments. * denotes statistic l significance. **: p < 0.01; ***: p < 
0.001. Scale bar: 5 µm. 
 
Figure 7. Tpm3.1 inhibition leads to the loss of voltage-gated sodium channels clustering at 
the AIS. 
(A) MAP2 and panNav immunofluorescence in rat hippocampal neurons incubated overnight at 
9-11 DIV in DMSO, LatB, or TR100. 
(B) Smoothed panNav fluorescence intensity line profiles (gray lines) along each neurite of the 
corresponding neuron in (A) normalized to the median v lue (black line). 
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(C) AIS localization indices for each group (Mann-Whitney U Test). Black circles represent 
mean value. Box borders represent the 25th and 75th percentiles, whiskers represent minimum and 
maximum values less than 1.5x the interquartile range lower or higher than the 25th or 75th 
percentiles, respectively (Tukey style). DMSO 0.2%: n = 17, 3 independent experiments; LatB 5 
µM: n = 17, 3 independent experiments; TR100 5 µM: n = 17, 3 independent experiments. * 
denotes statistical significance. ***: p < 0.001. Scale bar: 5 µm. 
 
Figure 8. Tpm3.1 inhibition leads to a reduction in firing frequency. 
(A) Individual traces from current-clamp (depolarizing step of 100 pA for 500 ms) recordings of 
rat hippocampal neurons in culture 2 and 15 minutes after treatments using either DMSO (0.2%) 
or Anisina (2.5 µM). 
(B) The percentage change in firing frequency 15 minutes after introducing each treatment 
relative to the firing frequency at 2 minutes. Anisi a-mediated inhibition of Tpm3.1 led to the 
attenuation of firing frequency 15 minutes after int oduction. Black circles represent mean value. 
Box borders represent the 25th and 75th percentiles, whiskers represent minimum and maximum 
values less than 1.5x the interquartile range lower or higher than the 25th or 75th percentiles, 
respectively (Tukey style). DMSO 0.2%: n = 7, 5 independent experiments; Anisina 2.5 µM: n = 
7, 5 independent experiments. * denotes statistical s gnificance, two-sample t-test. **: p < 0.01. 
(C) Representative somatic membrane potential record of an action potential in a cultured 
hippocampal neuron. The action potential was elicitd by current injection of 100 pA. Below, 
representative somatic membrane potential recording from a cultured hippocampal neuron with 
the Tpm3.1 inhibitor Anisina (2.5 µM) in the pipette filling solution. 
(D) Phase plots, the 1st derivative of the somatic membrane voltage (dV/dt) vs. membrane 
voltage (Vm) for control (DMSO, 0.2%) and Anisina-treated cultured hippocampal neurons. 
(E) Summary of phase plot slopes 20 mV above threshold. Anisina-treated neurons show a 
shallower phase plot slope 104.50 ± 9.66 dV/dt compared to control neurons 160.15 ± 10.60, n = 
5. * denotes statistical significance, two-sample t-t st. *: p < 0.05. 
(F) Summary of action potential thresholds at 10 mV/ s. -44.19 ± 2.256 mV for control and -




Figure 9. Tpm3.1 inhibition disrupts the periodicity of actin rings in the AIS. 
(A) SIM reconstructions of F-actin in the AIS of neurons treated at 14 DIV using DMSO, LatB, 
TR100, or Anisina (ATM3507), visualized using Alexa-488 tagged phalloidin. 
(B) Average autocorrelation of normalized fluorescence intensity profiles showing 
autocorrelation at 200 nm for all groups. 
(C) Distribution of distances between individual peaks in fluorescence intensity profiles for each 
group. The distribution of inter-peak distances in TR100- and Anisina-treated neurons was 
significantly different (p < 0.01) from DMSO- and LatB-treated neurons (Kolmogorov-Smirnov 
test). 
(D) The mean inter-peak distance and e coefficient of variation for individual cells in each group 
were not significantly different (Kruskal-Wallis ANOVA, p = 0.05 and p = 0.09, respectively). 
Black circles (D and E) represent mean value. Box borders represent the 25th and 75th percentiles, 
whiskers represent minimum and maximum values less than 1.5x the interquartile range lower or 
higher than the 25th or 75th percentiles, respectively (Tukey style). DMSO: n = 13 neurons, 4 
independent experiments; LatB: n = 13 neurons, 4 independent experiments; TR100: n = 13 
neurons, 3 independent experiments; Anisina: n = 13 neurons, 3 independent experiments. p 
values in (C) are relative to DMSO (Kolmogorov Smirnov test). Scale bar: 1 µm. See also Figure 
S10. 
 
Figure 10. Loss of Tpm3.1 leads to a reduction in myosin IIB immunofluorescence. 
Cultured hippocampal neurons of conditional Tpm3 knockout mice (Tp9 line). Arrowheads 
indicate neurons expressing Cre-GFP after either viral transduction (top panel) or lipofection 
(bottom panel). We used anti-myosin IIB to compare th  distribution of myosin IIB in neurons 
expressing Cre-GFP and neighboring control neurons. Cre-GFP expressing neurons showed a 
lower intensity of myosin IIB immunofluorescence (t test). Box borders represent the 25th and 
75th percentiles, whiskers represent minimum and maximum values less than 1.5x the 
interquartile range lower or higher than the 25th or 75th percentiles, respectively (Tukey style). 
Neurons expressing Cre-GFP; transduced: n = 12, 3 independent experiment; transfected n = 12, 
34 
 
3 independent experiments. Control neurons: transduced: n = 22; transfected: n = 31. * denotes 
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1) Tropomyosin isoform Tpm3.1 co-localizes with the actin cytoskeleton in the AIS 
  
2) Tpm3.1 inhibition led to a less organized AIS actin cytoskeleton 
  
3) Perturbation of Tpm3.1 function reduced the accumulation of AIS scaffolding proteins 
  
4) Tpm3.1 inhibition compromised cargo sorting and rapidly reduced firing frequency 
 
